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Abstract
Unmeasured confounding is a threat to causal inference and individualized decision
making. Similar to Cui and Tchetgen Tchetgen (2020); Qiu et al. (2020); Han (2020a), we
consider the problem of identification of optimal individualized treatment regimes with a
valid instrumental variable. Han (2020a) provided an alternative identifying condition of
optimal treatment regimes using the conditional Wald estimand of Cui and Tchetgen Tch-
etgen (2020); Qiu et al. (2020) when treatment assignment is subject to endogeneity and
a valid binary instrumental variable is available. In this note, we provide a necessary and
sufficient condition for identification of optimal treatment regimes using the conditional
Wald estimand. Our novel condition is necessarily implied by those of Cui and Tchet-
gen Tchetgen (2020); Qiu et al. (2020); Han (2020a) and may continue to hold in a variety
of potential settings not covered by prior results.
keywords: Individualized decision making, policy making, optimal treatment regimes,
unmeasured confounding, sign identification, conditional average treatment effect
1
ar
X
iv
:2
01
0.
03
39
0v
1 
 [m
ath
.ST
]  
7 O
ct 
20
20
1 Introduction
Estimating optimal treatment regimes is a central task for precision medicine. In the
health sciences and medicine, an individualized treatment regime provides a personalized
treatment strategy for each patient in the population based on individual characteristics.
A prevailing strand of work has been devoted to estimating optimal treatment regimes
(Robins et al. (2000); Murphy (2003); Qian and Murphy (2011); Zhao et al. (2012); Zhang
et al. (2012a) and many others), we refer to Chakraborty (2013); Kosorok and Laber
(2019); Tsiatis et al. (2019) for an up-to-date literature review on dynamic treatment
regimes.
Recently, there has been a fast-growing literature on estimating individualized treat-
ment regimes based on observational studies subject to potential unmeasured confound-
ing (Kallus and Zhou, 2018; Yadlowsky et al., 2018; Kallus et al., 2019; Cui and Tch-
etgen Tchetgen, 2020; Qiu et al., 2020; Han, 2020a,b). In particular, Cui and Tchet-
gen Tchetgen (2020) and Qiu et al. (2020) tackled the problem of individualized decision
making/estimating individualized treatment regimes by leveraging a valid instrumental
variable (IV) to account for potential unmeasured confounding. Han (2020a) provided
an alternative identifying condition under which the conditional Wald estimand on which
identification is based on in Cui and Tchetgen Tchetgen (2020); Qiu et al. (2020) continues
to identify optimal treatment regimes.
In this paper, we further relax sufficient identifying conditions considered by Cui and
Tchetgen Tchetgen (2020); Qiu et al. (2020); Han (2020a), and introduce the concept of
identifying optimal treatment regimes by only identifying the sign of conditional average
treatment effect (CATE). We propose a necessary and sufficient identification condition
based on the possibility of identifying the sign of the CATE from the conditional Wald
estimand without necessarily being able to identify the CATE nor the population value
function for any given treatment regime. We illustrate the result by exploring realistic
scenarios in which conditional optimal treatment regime can be identified in settings in
which identifying conditions of Cui and Tchetgen Tchetgen (2020); Qiu et al. (2020); Han
(2020a) are not met.
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To conclude this section, we briefly introduce notation used throughout the paper.
Let Y denote the outcome of interest and A ∈ {−1, 1} be a binary treatment indicator.
Throughout it is assumed without loss of generality that larger values of Y are more
desirable. Suppose that U is an unmeasured confounder of the effect of A on Y . Suppose
also that one has observed a pre-treatment binary IV Z ∈ {−1, 1}. Let L denote a
set of fully observed pre-IV covariates. Throughout we assume the complete data are
independent and identically distributed realizations of (Y,L,A,Z, U); thus the observed
data are (Y,L,A,Z).
2 IV approaches to optimal treatment regimes
We wish to identify an optimal treatment regime D∗, which is a mapping from the patient-
level covariate space to the treatment space {−1, 1} that maximizes the corresponding
expected potential outcome for the entire population, i.e.,
D∗(L) = sign{γ(L)} = arg max
D
EL
[
EYD [YD(L)|L]
]
, (1)
where γ(L) ≡ E(Y1−Y−1|L) 6= 0, Ya is a person’s potential outcome under an intervention
that sets the treatment to value a, and YD(L) is the potential outcome under a hypothetical
intervention that assigns treatment according to the regime D, i.e.,
YD(L) ≡ Y1I{D(L) = 1}+ Y−1I{D(L) = −1},
where I{·} is the indicator function. Throughout the paper, we make the standard con-
sistency and positivity assumptions as in Cui and Tchetgen Tchetgen (2020).
A significant amount of work has been devoted to estimating optimal treatment regimes
relying on the following unconfoundedness assumption:
Assumption 1. (Unconfoundedness) Ya ⊥⊥ A|L for a = ±1.
The assumption essentially rules out the existence of an unmeasured factor U that
confounds the effect of A on Y upon conditioning on L. It is straightforward to verify
that under Assumption 1, one can identify the value function (Qian and Murphy, 2011)
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E[YD(L)] for a given treatment regime D. Furthermore, the optimal treatment regime in
Equation (1) is identified from the observed data
D∗(L) = sign{E(Y |A = 1, L)− E(Y |A = −1, L)}.
As established by Qian and Murphy (2011), learning optimal treatment regimes under
Assumption 1 can be formulated as
D∗ = arg max
D
E
[
Y I{D(L) = A}
f(A|L)
]
.
Zhang et al. (2012b) proposed to directly maximize the value function over a parametrized
set of functions. Rather than maximizing the above value function, Zhao et al. (2012);
Zhang et al. (2012a); Rubin and van der Laan (2012) transformed the above problem
into a weighted classification approach, which was shown to have appealing robustness
properties, particularly in a randomized study where no model assumption on Y is needed.
Instead of relying on Assumption 1, we allow for unmeasured confounding. Let Yz,a
denote the potential outcome had, possibly contrary to fact, a person’s IV and treatment
value been set to z and a, respectively. Suppose that the following assumption holds.
Assumption 2. (Latent unconfoundedness) Yz,a ⊥⊥ (Z,A)|L,U for z, a = ±1.
This assumption essentially states that together U and L would in principle suffice
to account for any confounding bias. Because U is not observed, we propose to account
for it when a valid IV Z is available that satisfies the following standard IV assumptions
(Angrist et al., 1996):
Assumption 3. (IV relevance) Z 6⊥⊥ A|L.
Assumption 4. (Exclusion restriction) Yz,a = Ya for z, a = ±1 almost surely.
Assumption 5. (IV independence) Z ⊥⊥ U |L.
Assumption 6. (IV positivity) 0 < f (Z = 1|L) < 1 almost surely.
Assumptions 3-5 are well-known IV conditions, while Assumption 6 is needed for non-
parametric identification (Greenland, 2000; Hernan and Robins, 2006). Assumption 3
4
requires that the IV is associated with the treatment conditional on L. Note that As-
sumption 3 does not rule out confounding of the Z-A association by an unmeasured factor,
however, if present, such factor must be independent of U . Assumption 4 states that there
can be no direct causal effect of Z on Y not mediated by A. Assumption 5 states that the
direct causal effect of Z on Y would be identified conditional on L if one could intervene
on A = a. Hereinafter, we refer to Assumptions 3-6 as core IV assumptions. Figure 1
provides a graphical representation of Assumptions 4 and 5.
A
U
Y
L
Z
Figure 1: Causal directed acyclic graph with unmeasured confounding. The bi-directed arrow
between Z and A indicates the possibility that there may be unmeasured common causes
confounding their association.
These four core IV assumptions together do not suffice for point identification of the
counterfactual mean and average treatment effect. Cui and Tchetgen Tchetgen (2020)
showed that D∗ is nonparametrically identified by
arg max
D
E
[
ZAY I{A = D(L)}
δ(L)f(Z|L)
]
, (2)
and
arg max
D
E
[
Y I{Z = D(L)}
δ(L)f(Z|L)
]
, (3)
under no unmeasured common effect modifier assumption, i.e.,
Cov
{
δ˜(L,U), γ˜(L,U)|L
}
= 0,
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almost surely, where δ˜(L,U) ≡ Pr(A = 1|Z = 1, L, U) − Pr(A = 1|Z = −1, L, U) and
γ˜(L,U) ≡ E(Y1 − Y−1|L,U), respectively, or independent compliance type assumption,
i.e.,
δ(L) ≡ Pr(A = 1|Z = 1, L)− Pr(A = 1|Z = −1, L) = δ˜(L,U) almost surely.
Han (2020a) proposed the following alternative identifying assumption for (2) and (3) to
identify optimal treatment regimes given for a causal IV: The following two conditions
hold given L,
(a) either E[Y1|L,U ] ≥ E[Y−1|L,U ] or E[Y1|L,U ] ≤ E[Y−1|L,U ] almost surely; and
(b) either E[A1|L,U ] ≥ E[A−1|L,U ] or E[A1|L,U ] ≤ E[A−1|L,U ] almost surely.
3 Individualized treatment regimes: Identifying
the sign of CATE
We note that in order to identify optimal treatment regimes, one only needs to identify
the sign of CATE. Therefore, in the following theorem, we provide sufficient and necessary
conditions for Equations (2) and (3) identifying D∗, or equivalently, the conditional Wald
estimand C(L)/δ(L) in Wald (1940); Wang and Tchetgen Tchetgen (2018) having the
same sign as γ(L), where C(L) ≡ E(Y |Z = 1, L)− E(Y |Z = −1, L).
Theorem 3.1. Under Assumptions 2-6, the following condition is necessary and sufficient
for Equation (2) or (3) identifying D∗(L),
E
(
γ˜(L,U)
γ(L)
× δ˜(L,U)
δ(L)
∣∣∣∣L) > 0, (4)
or equivalently,
Cov
(
γ˜(L,U)
γ(L)
,
δ˜(L,U)
δ(L)
∣∣∣∣L) > −1. (5)
The necessary and sufficient identifying condition clearly holds if
Cov
(
γ˜(L,U)
γ(L)
,
δ˜(L,U)
δ(L)
∣∣∣∣L) ≥ 0, (6)
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which essentially states that γ˜(L,U)γ(L) and
δ˜(L,U)
δ(L) are positively correlated conditional on L.
This would hold for instance if both functions are either non-increasing or non-decreasing
as functions of U whenever U is scalar. Importantly, this assumption may hold if either
γ˜(L,U) or δ˜(L,U) is positive for some values of U and negative for other values conditional
on L such that the sign of say δ˜(L,U) does not always agree with that of δ(L) therefore
invalidating the assumption of Han (2020a) (even if a causal IV is assumed in Han (2020a)).
The theorem establishes that optimal treatment regimes are identified by the sign
of the conditional Wald estimand (Wald, 1940; Wang and Tchetgen Tchetgen, 2018) in
the setting where individuals’ decision to uptake the intervention is concordant with an
anticipated benefit from the intervention. Specifically, consider the following definition
of concordant treatment uptake with anticipated benefit from the intervention in the
special case where U can be taken as univariate: a) E(Y1 − Y−1|L,U) and E(A|Z =
1, L, U) − E(A|Z = −1, L, U) are both non-decreasing or non-increasing in U so that
as anticipated expected treatment benefit increases with U , expected treatment uptake
likewise increases in U ; b) sign{E(Y1−Y−1|L)} = sign{E(A|Z = 1, L)−E(A|Z = −1, L)}
so that conditional on L, patients’ expected decision to uptake the intervention matches
their expected treatment benefit. We refer to subjects with an ability to fulfill both a) and
b) as rational agents with perfect anticipation. It is then clear according to the theorem
that if all subjects are rational agents with perfect anticipation, optimal treatment regimes
can be identified on the basis of the sign of the conditional Wald estimand. Importantly,
the theorem allows for some portion of the population of subjects failing to be rational
possibly due to imperfect anticipation of expected treatment benefit; provided that they
do not offset the contribution to the conditional Wald estimand from rational agents with
perfect anticipation of expected treatment benefit.
Our necessary and sufficient condition is also clearly implied by those of Cui and
Tchetgen Tchetgen (2020); Qiu et al. (2020); Han (2020a). The assumption of Cui and
Tchetgen Tchetgen (2020) corresponds to the case Cov
{
δ˜(L,U), γ˜(L,U)|L
}
= 0; while
that of Han (2020a) given for a causal IV: Conditional on L,
(a) either E[Y1|L,U ] ≥ E[Y−1|L,U ] or E[Y1|L,U ] ≤ E[Y−1|L,U ] almost surely; and
(b) either E[A1|L,U ] ≥ E[A−1|L,U ] or E[A1|L,U ] ≤ E[A−1|L,U ] almost surely;
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imply Equation (4) as it implies the sign of γ˜(L,U) agrees with the sign of γ(L) almost
surely and likewise the sign of δ˜(L,U) agrees with that of δ(L) almost surely.
Finally, it is notable that the above theorem allows for identification of optimal treat-
ment regimes with Equation (2) or (3) even when an unmeasured confounding factor is an
effect modifier of both the first stage association between the IV and the endogenous treat-
ment, and of the causal effect of the endogenous treatment on the outcome; a possibility
first recognized by Han (2020a) which we have hereby significantly expanded upon.
4 Three levels of assumptions for identifying op-
timal treatment regimes
In this section, as a summary, one may categorize various assumptions for identifying
optimal treatment regimes into three levels, namely depending on whether one can identify
the value function, the CATE, or only the sign of CATE in Table 1.
In particular, as for identifying the CATE, Assumption A5b(1b) of Qiu et al. (2020)
is a special case of Assumption 7 of Cui and Tchetgen Tchetgen (2020), while Assump-
tion A5b(1a) of Qiu et al. (2020) relaxes IV independence to uncorrelated IV. As for
identifying the sign of CATE, while both imply Equation (4) or (5), Assumption A of
Han (2020a) and Equation (6) do not necessarily imply each other. Moreover, nonpara-
metric IV bounds such as Balke-Pearl bounds (Balke and Pearl, 1997) can be used to
identify the sign of CATE when not covering zero (Cui and Tchetgen Tchetgen, 2020).
Interestingly, we point out that while, on the left side of Table 1, the quantity that
is identified is stronger from bottom to top, identifying assumptions in the top do not
necessarily imply those in the bottom on the right side. For instance, Assumption 7 of Cui
and Tchetgen Tchetgen (2020) and Assumption A of Han (2020a) do not necessarily imply
each other because no heterogeneity in U of the compliance type or the average additive
treatment effect on the outcome implies Assumption 7 of Cui and Tchetgen Tchetgen
(2020) without implying Assumption A of Han (2020a); and the latter assumption does
not necessarily imply the no common unmeasured effect modifier condition.
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Quantity Identified Identifying Assumptions
the value function Assumption 8 of Cui and Tchetgen Tchetgen (2020), Assumption A5b(2) of Qiu et al. (2020)
the CATE Assumption 7 of Cui and Tchetgen Tchetgen (2020), Assumption A5b(1) of Qiu et al. (2020)
the sign of CATE Assumption A of Han (2020a), Equation (4) or (5) or (6), IV CATE bounds when not covering 0
Table 1: A categorization of various identifying assumptions in Cui and Tchetgen Tchetgen
(2020), Qiu et al. (2020), and Han (2020a) for identifying the value function, CATE, and sign
of CATE.
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Appendix
A Proof of Theorem 3.1
Proof. From the proof of Theorems 2.1 and 2.2 in Cui and Tchetgen Tchetgen (2020), we
have
E
[
ZAY I{A = D(L)}
δ(L)f(Z|L)
]
=E
[
[Pr(A = 1|Z = 1, L, U)− Pr(A = 1|Z = −1, L, U)] I{D(L) = 1}E[Y1|L,U ]
δ(L)
]
+E
[
[Pr(A = 1|Z = 1, L, U)− Pr(A = 1|Z = −1, L, U)] I{D(L) = −1}E[Y−1|L,U ]
δ(L)
]
,
and
E
[
Y I{Z = D(L)}
δ(L)f(Z|L)
]
=E
[
[Pr(A = 1|Z = 1, L, U)− Pr(A = 1|Z = −1, L, U)] I{D(L) = 1}E[Y1|L,U ]
δ(L)
]
+E
[
[Pr(A = 1|Z = 1, L, U)− Pr(A = 1|Z = −1, L, U)] I{D(L) = −1}E[Y−1|L,U ]
δ(L)
]
+E
[
Pr(A = 1|Z = −1, L, U)E[Y1|L,U ]
δ(L)
]
+E
[
Pr(A = −1|Z = −1, L, U)E[Y−1|L,U ]
δ(L)
]
.
It easy to see that
arg max
D
E
[
ZAY I{A = D(L)}
δ(L)f(Z|L)
]
,
and
arg max
D
E
[
Y I{Z = D(L)}
δ(L)f(Z|L)
]
,
equal to
arg max
D
E
[
γ˜(L,U)δ˜(L,U)
δ(L)
I{D(L) = 1}
]
, (7)
which is denoted by D˜. This completes the proof as D˜(L) necessarily agrees with the sign
of γ(L) whenever Equation (4) holds.
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The proof can also be conducted from the perspective of conditional Wald estimand.
Recall that
C(L) =E{E[Y |Z = 1, L, U ]− E[Y |Z = −1, L, U ]∣∣L}
=E
{
E[Y1
1 +A
2
|Z = 1, L, U ] + E[Y−1 1−A
2
|Z = 1, L, U ]∣∣L}
− E{E[Y1 1 +A
2
|Z = −1, L, U ] + E[Y−1 1−A
2
|Z = −1, L, U ]∣∣L}
=E
(
E[Y1 − Y−1|L,U ]
{
Pr[A = 1|Z = 1, L, U ]− Pr[A = 1|Z = −1, L, U ]
}∣∣∣∣L)
=E
(
γ˜(L,U)δ˜(L,U)
∣∣∣L).
Thus, we have that
C(L)
δ(L)
= E
( γ˜(L,U)δ˜(L,U)
δ(L)
∣∣∣L).
Subsequently,
C(L)
δ(L)
/γ(L) = E
(
γ˜(L,U)
γ(L)
× δ˜(L,U)
δ(L)
∣∣∣∣L).
Also note that
Cov
(
γ˜(L,U)
γ(L)
,
δ˜(L,U)
δ(L)
∣∣∣∣L)+ 1
=E
(
γ˜(L,U)
γ(L)
× δ˜(L,U)
δ(L)
∣∣∣∣L),
which completes the proof as the sign of γ(L) will necessarily agree with that of the
conditional Wald estimand whenever the expression in above display is positive.
B Identifying assumptions in Table 1
For easy referencing, we provide identifying assumptions appeared in Table 1.
• Assumption 7 of Cui and Tchetgen Tchetgen (2020) (No unmeasured common effect
modifier): Cov
{
δ˜(L,U), γ˜(L,U)|L
}
= 0 almost surely.
• Assumption 8 of Cui and Tchetgen Tchetgen (2020) (Independent compliance type):
δ(L) = δ˜(L,U) almost surely.
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• Assumption A5b(1) of Qiu et al. (2020): Both conditions below hold:
(a) (Uncorrelated IV) Cov(Y−1, Z|L) = 0 almost surely;
(b) (No unmeasured treatment-outcome effect modification) E[Y1 − Y−1|L,U ] =
E[Y1 − Y−1|L] almost surely.
• Assumption A5b(2) of Qiu et al. (2020): Both conditions below hold:
(a) (Independent IV) Z and U are independent given L;
(b) (Independent compliance) E[AZ |Z = 1, L, U ]−E[AZ |Z = −1, L, U ] = E[A|Z =
1, L]− E[A|Z = −1, L] almost surely.
• Assumption A of Han (2020a): The following two conditions hold given L,
(a) either E[Y1|L,U ] ≥ E[Y−1|L,U ] or E[Y1|L,U ] ≤ E[Y−1|L,U ] almost surely; and
(b) either E[A1|L,U ] ≥ E[A−1|L,U ] or E[A1|L,U ] ≤ E[A−1|L,U ] almost surely.
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